Table. Sociodemographic and clinical characteristics at the start of the study.
|
Yoga A (n = 25) |
Yoga B (n = 25) |
Control (n = 25) |
|
| Sociodemographic characteristics | |||
| Age, years*1 | 59.4 ± 9.1 | 56.5 ± 10.6 | 57.0 ± 8.7 |
| Sex | |||
| Female*2 | 18 (72.0%) | 18 (72.0%) | 18 (72.0%) |
| Male*2 | 7 (28.0%) | 7 (28.0%) | 7 (28.0%) |
| Height, cm*1 | 171.3 ± 8.9 | 169.6 ± 8.2 | 168.0 ± 8.0 |
| Weight, kg*1 | 85.4 ± 15.2 | 87.9 ± 27.9 | 80.5 ± 13.5 |
| Marital status*2 | |||
| Married/stable partnership | 4 (16.0%) | 4 (16.0%) | 7 (28.0%) |
| Single | 21 (84.0%) | 21 (84.0%) | 17 (72.0%) |
| Education*3 | |||
| Year 9 lower secondary school certificate (Hauptschulabschluss) |
5 (20.0%) | 3 (12.0%) | 8 (32.0%) |
| Year 10 intermediate secondary school certificate (Realschulabschluss) |
14 (56.0%) | 10 (40.0%) | 7 (28.0%) |
| University entrance qualification | 2 (8.0%) | 4 (16.0%) | 5 (20.0%) |
| University/technical university degree | 4 (16.0%) | 8 (32.0%) | 4 (16.0%) |
| Occupation*2 | |||
| Employed full-time | 2 (8.0%) | 5 (20.0%) | 8 (32.0%) |
| Employed part-time | 8 (32.0%) | 9 (36.0%) | 4 (16.0%) |
| Unemployed | 15 (60.0%) | 11 (44.0%) | 13 (52.0%) |
| Blood pressure, mmHg*1 | |||
| Systolic/24 h | 135.4 ± 11.6 | 131.7 ± 11.3 | 133.3 ± 9.8 |
| Diastolic/24 h | 82.5 ± 10.3 | 81.1 ± 10.9 | 81.1 ± 9.1 |
| Systolic, diurnal | 137.1 ± 11.5 | 133.4 ± 11.7 | 135.5 ± 9.3 |
| Diastolic, diurnal | 84.2 ± 10.5 | 82.5 ± 11.3 | 82.7 ± 9.2 |
| Systolic, nocturnal | 122.4 ± 16.0 | 121.0 ± 11.8 | 120.0 ± 15.1 |
| Diastolic, nocturnal | 71.5 ± 12.0 | 72.7 ± 9.3 | 71.2 ± 10.4 |
| Heart rate, beats/min*1 | |||
| 24 h | 73.0 ± 12.4 | 73.5 ± 10.1 | 70.8 ± 7.6 |
| Diurnal | 74.2 ± 12.9 | 75.0 ± 10.1 | 72.2 ± 7.9 |
| Nocturnal | 65.2 ± 10.7 | 63.1 ± 7.7 | 62.1 ± 6.3 |
| Expectation of effect | 7.3 ± 1.7 | 6.1 ± 2.1 | 3.9 ± 2.3 |
| Antihypertensive medication*2 | |||
| ACE inhibitors/AT1-receptor blockers | 21 (84.0%) | 23 (92.0%) | 23 (92.0%) |
| Diuretics | 10 (40.0%) | 9 (36.0%) | 10 (40.0%) |
| Beta blockers | 13 (52.0%) | 8 (32.0%) | 6 (24.0%) |
| Calcium channel blockers | 9 (36.0%) | 8 (32.0%) | 9 (36.0%) |
| Alpha blockers | 2 (8.0%) | 1 (4.0%) | 5 (20.0%) |
*1 Mean ± standard deviation; *2 n (% of n); *3 Data on education were missing for one patient